[1]
B. Strober, “Efficacy and Safety of Apremilast in Patients with Moderate Plaque Psoriasis with Lower BSA (UNVEIL Phase IV Study)”, J of Skin, vol. 1, no. 3.1, p. s11, Oct. 2017.